Category

• Events1
• Pipeline1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Cell Therapy2
• Clinical Trials2
• Retina2
• Ophthalmology Tech Forum1
• Cornea1
• Genetic Testing1
• Inherited Retinal Disease1
• Ophthalmic Tech1
• Ophthalmology1
• Retinitis Pigmentosa1

• Organizations: jCyte✕

Clear all

Pipeline

jCyte doses first patients in RP allogeneic cell therapy trial

Phase 2b JC02-88 trial to evaluate a single IVT injection of jCell (famzeretcel), an agnostic cell therapy with the potential to restore vision in all RP genetic subtypes.

Events

KOLs eye the future of genetic engineering and cell transplantation

Industry leaders from four leading ophthalmic companies debut the latest clinical developments in cell-based therapeutics.